Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease
@article{Bagazgoitia2010ExpressionOP, title={Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease}, author={Lorea Bagazgoitia and Jes{\'u}s Cuevas and {\'A}ngeles Juarranz}, journal={Journal of the European Academy of Dermatology and Venereology}, year={2010}, volume={24} }
Introduction Bowen's disease (BD) and bowenoid actinic keratosis (bAK) have traditionally been differentiated according to the presence or absence of dysplasia in the follicular epithelium. p16 has been suggested to be a useful tool to make the differential diagnosis between BD and AK and as a marker of bad prognosis.
31 Citations
Atypical intraepidermal keratinocytic lesions falling short of carcinoma in situ (Bowen disease) on routine staining: the utility of p16 immunostaining
- MedicineJournal of cutaneous pathology
- 2014
Keywords:
actinic keratosis;
Bowen disease;
p16;
seborrheic keratosis;
squamous cell carcinoma in situ
Clonal highlights: Clonal seborrheic keratoses often demonstrates p16 expression
- BiologyJournal of cutaneous pathology
- 2019
This work investigates p16 immunohistochemistry in CSK, SK, and BD to find out if there is a relationship between CSK and p16 expression and Bowen disease.
Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study
- MedicineJournal of cutaneous pathology
- 2012
This work has shown that differentiation between keratoacanthoma and hypertrophic lichen planus histopathologically can be difficult, and the challenge is compounded by the tendency of KA to arise in association with hypertrophic LP.
Claudin‐1 expression decreases with increasing pathological grade in actinic keratosis and may be a marker of high‐risk actinic keratosis
- MedicineClinical and experimental dermatology
- 2019
There is still no reliable method to predict high‐risk AK, but there is a growing awareness of the need to understand more fully the risks and benefits of sun‐induced keratosis.
Acantholytic Variant of Bowen's Disease with Micro-invasive Squamous Cell Carcinoma: A Case Report of a Unique Variant
- MedicineIndian journal of dermatology
- 2014
A case of unusual acantholytic variant of Bowen's disease with focus of micro-invasive carcinoma is presented.
p16 immunostaining in keratinocytic neoplasia in organ transplant recipients: Bowen's disease shows a characteristic pattern
- MedicineJournal of cutaneous pathology
- 2017
For selecting therapy, it is important to distinguish different types of keratinocytic neoplasia, especially in organ transplant recipients (OTR) who develop numerous lesions.
Clonal Seborrheic Keratosis Versus Pagetoid Bowen Disease: Histopathology and Role of Adjunctive Markers
- MedicineThe American Journal of dermatopathology
- 2017
There is no single reliable criterion to distinguish CSK from PBD, but a panel of markers comprising CK10, Ki-67, and p16 seems to be useful in the context of relevant histology.
Different Immunohistochemical Localization of Fatty Acid Binding Protein 5 in Actinic Keratosis Compared with That in Bowen's Disease: A Retrospective Study.
- Medicine, BiologyThe American Journal of dermatopathology
- 2020
The unique immunohistochemical localization of the FABP5 can be a helpful diagnostic marker, and altered fatty acid metabolism may be the key in understanding the different pathophysiology of AK and BD.
Detection of Merkel Cell Polyomavirus in Seborrheic Keratosis
- BiologyFront. Microbiol.
- 2018
Investigation of the presence of Merkel cell polyomavirus (MCPyV) in relation to p16 expression in Seborrheic keratosis found it to be a coincidental infection, and P16 IHC does not appear as useful adjunctive surrogate marker for the existence of MCPYV in SK.
Immunohistochemical staining for p16 is a useful adjunctive test in the diagnosis of Bowen's disease
- MedicinePathology
- 2013
Bowen's disease shows a distinctive, repeatable pattern of staining with p16, characterised by moderate to strong staining of all abnormal cells with sparing of a layer of basal cells, which is not seen in actinic keratosis or in seborrheic keratoses.
References
SHOWING 1-10 OF 15 REFERENCES
p16INK4a expression in actinic keratosis and Bowen's disease
- MedicineThe British journal of dermatology
- 2003
Background Progression of cutaneous squamous neoplasms from actinic keratosis (AK) to Bowen's disease (BD; squamous cell carcinoma in situ) has important implications for clinical management and…
Correlation of p16 and pRb expression with HPV detection in Bowen’s disease
- MedicineJournal of cutaneous pathology
- 2006
It is shown that p16 over‐expression is a surrogate marker of HPV E7‐mediated catabolism of pRb in premalignant and malignant lesions of the cervical mucosa and the correlation of p16 and pRB expression with HPV detection in Bowen’s disease has not been well characterized.
An Assessment of the Malignant Potential of Actinic Keratoses and Bowen's Disease: p53 and PCNA Expression Pattern Correlate with the Number of Desmosomes
- MedicineThe Journal of dermatology
- 2002
It is hypothesized that atrophic and acantholytic types of AK might have the lowest, and the bowenoid type of AK and BD may have the highest, malignant potential.
Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor.
- MedicineCancer letters
- 2002
Low prevalence of p53, p16INK4a and Ha‐ras tumour‐specific mutations in low‐graded actinic keratosis
- MedicineThe British journal of dermatology
- 2007
Different mutation rates of p53, p16INK4a and Ha‐ras in cutaneous squamous cell carcinoma and the earlier stage actinic keratosis have been reported.
Immunophenotypic analysis of the p53 gene in non‐melanoma skin cancer and correlation with apoptosis and cell proliferation
- Medicine, BiologyJournal of the European Academy of Dermatology and Venereology : JEADV
- 2005
The p53 tumour suppressor gene, which plays a pivotal role in cell division and apoptosis, is frequently found mutated in sunlight‐induced skin tumours.
Immunohistochemical Staining of Palisading Basal Cells in Bowen's Disease and Basal Involvement in Actinic Keratosis: Contrasting Staining Patterns Suggest Different Cells of Origin
- Biology, MedicineThe American Journal of dermatopathology
- 2008
Lack of expression of proliferative antigens in palisading basal cells in BD provides evidence that PBCs are not the cell of origin for BD, whereas in AK, expression of MIB-1 and p53 in basal cells argues that these cells play a role in histogenesis of AK.
P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas.
- MedicineEuropean journal of dermatology : EJD
- 2006
It is demonstrated that the expression of P16 and Ki67 is associated with skin carcinomas, and within cutaneous carcinoma specimens, P16 overexpression was significantly associated with the location on sun-exposed areas, suggesting a possible induction of P 16 overeexpression by UV radiation.
Immunohistochemical Comparison of P16 Expression in Actinic Keratoses and Squamous Cell Carcinomas of the Skin
- MedicineModern Pathology
- 2002
There are approximately 200,000 new cases of cutaneous squamous cell carcinoma diagnosed each year in the United States, with between 1300 and 2300 deaths per year from metastatic disease. The tumor…
Bowen's Disease: A Four‐Year Retrospective Review of Epidemiology and Treatment at a University Center
- MedicineDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
- 2008
The most common locations for BD were in areas with high sun exposure and multiple treatment options are available and recurrence is uncommon, but Margin control surgery should be considered for tumors in high-risk areas.